Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy Stifel Nicolaus

Start price
€45.00
22.01.25 / 50%
Target price
€76.65
22.01.26
Performance (%)
22.22%
End price
€55.00
23.01.26
Summary
This prediction ended on 23.01.26 with a price of €55.00. The BUY prediction by Stifel_Nicolaus finished with a performance of 22.22%. Stifel_Nicolaus has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. 2.274% 2.274% 62.874%
iShares Core DAX® 3,59 % 3,93 % 15,38 %
iShares Nasdaq 100 5,81 % 5,52 % 41,46 %
iShares Nikkei 225® 4,08 % 8,46 % 48,95 %
iShares S&P 500 4,14 % 4,04 % 31,59 %

Comments by Stifel_Nicolaus for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) 22.22%
Target price 76.648
Change
Ends at 22.01.26

Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $80.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat

In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) 22.22%
Target price 76.648
Change
Ends at 22.01.26

Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten

Current prediction by Stifel_Nicolaus for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.80
02.09.25
€82.03
02.09.26
38.92%
17.04.26